In summary, our meta-analysis indicates that HSPs serve as accurate biomarkers suitable for clinical use in the diagnosis of HCC, and the combination of HSPs and AFP significantly enhances diagnostic value compared to HSPs or AFP alone. Here, AFP is linked to hepatocellular carcinoma.